# Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

> **NCT00154401** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 177 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide

## Key facts

- **NCT ID:** NCT00154401
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154401, "Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00154401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*